Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test
On Mar. 19, 2020, Mesa Biotech announced it has significantly expanded its capacity to test clinical samples for…
On Mar. 19, 2020, Mesa Biotech announced it has significantly expanded its capacity to test clinical samples for…
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…
On Jul. 12, 2018, Cue Health announced that is had been awarded up to $30 million in base…
On Jul. 13, 2010, Bavarian Nordic announced that it had delivered 1 million doses of its smallpox vaccine…